Abstract:Objective:To investigate the effectiveness of surgical treatment for patients with T 4 stage prostate cancer. Methods:The clinical data and prognosis of 18 patients with T 4 stage prostate cancer treated in Shanghai Tenth People's Hospital from July 2013 to December 2019 were retrospectively analyzed. The average age of these 18 patients was 68.3 (53-81)years. 10 patients were castration resistant prostate cancer (CRPC) and 8 patients were hormone-sensitive prostate cancer (HSPC). 10 CRPC patients were treated with surgical treatment due to bladder clot packing and/or lower urinary tract obstruction. 8 HSPC patients had severe hematuria, severe dysuria and local symptoms. The KPS scores of all patients were ≥80 points with an average score of 84 (80-90). The average QOL score of 18 patients was 28 (21-32). 2 cases in 18 patients underwent total pelvic resection for rectal invasion (one CRPC and one HSPC). 7 cases underwent radical cystoprostatectomy for ureteral invasion (5 cases of CRPC, 2 cases of HSPC), 9 cases underwent bladder preservation surgery for bladder neck invasion (4 cases of CRPC, 5 cases of HSPC), of which 4 cases of enlarged lymph node dissection were all HSPC patients. Results:All cases of T 4 stage prostate cancer patients operation were successfully completed, the average operation time was 256 (219-310)min and the median intraoperative blood loss was about 300 (250-350)ml. Four of them (3 cases of CRPC and 1 case of HSPC) received blood transfusion after operation. The average postoperative hospital stay was 21(11-37) days. All 18 cases were followed up and the median follow-up time was 23.8 months. There was no perioperative death, and no bladder-preserving patients had true urinary incontinence or bladder outlet stenosis.2 CRPC cases died 8 and 15 months after surgery respectively, 7 patients were PSA relapse treated with docetaxel or abiterone therapy, and 1 HSPC patient with rectal invasion was followed up for 58 months after total pelvic resection, the PSA level was still 0.003ng/ml, no distant metastasis was found. 8 cases of hormone-sensitive patients were treated with endocrine therapy, and PSA was less than 0.2 ng/ml. The average QOL of 18 patients 3 months after operation was 37 points (25-45), which was significantly higher than that before operation. The average maximum urine flow rate of patients with bladder preservation was 23(19-25)ml/s. Conclusions:For T 4 stage prostate cancer, surgical treatment is feasible and safe for doctors with extensive surgical experience. For CRPC patients, the surgery can significantly improve short-term symptoms and quality of life, and long-term benefits need to be further evaluated with a large sample. For HSPC patients, it can not only improve clinical symptoms and QOL of patients, but also provide long-term benefits.

Long-term Outcome of Transurethral Resection of Prostate in Patients with Advanced Prostate Cancer and Bladder Outlet Obstruction

The value of transurethral cylindrical dilatation of the prostate in the treatment of patients with benign prostatic hyperplasia

High-risk benign prostatic hyperplasia patients treated with transurethral resection of prostate

A comparative study of two means of simultaneous treatment for benign prostate hyperplasia and bladder stone

Effect Observation of TURP Combined with Androgen Blockade for Advanced Prostate Cancer with Bladder Outlet Obstruction

Evaluation of Long - Term Effect of Transurethral Resection of Prostate

[Efficacy and Outcome of Palliative TURP in Patients with Bladder Outlet Obstruction Induced by Advanced Prostate Cancer].

Transurethral prostate resection for advanced prostate cancer in patients with bladder outlet obstruction

Long-term Outcomes of Bipolar Transurethral Enucleation and Resection of the Prostate on Patients with Benign Prostatic Obstruction: a 10-Year Follow-Up

Experience in treating advanced prostate cancer with bladder outlet obstruction]

[TURP plus endocrine therapy (ET) versus α1A-blockers plus ET for bladder outlet obstruction in advanced prostate cancer]

Transurethral Resection of Prostate for Treatment of High-risk Patients with Large Volume Benign Prostatic Hyperplasia

Effect of transurethral resection of prostate on quality of life in aged patients with benign prostatic hyperplasia

Transurethral Procedure for Bladder Outlet Obstruction Caused by Small-size Prostatic Hyperplasia

Transurethral vapor-resection of prostate combined with epididymal sparing bilateral simple orchiectomy for advanced prostate cancer patients with bladder outlet obstruction

The effect of bladder function on the efficacy of transurethral prostatectomy in patients with benign prostatic hyperplasia: a retrospective, single-center study

Clinical Observation of Plasma Kinetic Resection of Prostate Combined with Endocrine Therapy in the Treatment of Advanced Prostate Cancer with Bladder Outlet Obstruction

Quality of Life among Patients after Cystoprostatectomy As the Treatment for Locally Advanced Prostate Cancer with Bladder Invasion.

The experience of surgical treatment in T 4 stage prostate cancer

Bipolar Transurethral Enucleation and Resection of the Prostate Versus Bipolar Resection of the Prostate for Prostates Larger Than 60gr: A Retrospective Study at a Single Academic Tertiary Care Center

Analysis of Improved Lower Urinary Tract Symptoms Following Transurethral Resection of Prostate